Is Camelot a Good Investment?

B-Value
BRisk
|DEX
Loading price data...
TVL$20M
FDV$108M
TVL/FDV0.19x
Risk GradeB
Value GradeB-

Value Accrual: Does the Camelot Token Capture Value?

Camelot scores B- on Hindenrank's value accrual framework (61/100), indicating solid value fundamentals with room for improvement in one or two dimensions. Fee capture scores 16/25 — solid, capturing a reasonable share of protocol revenue. Token distribution is rated 13/25 (somewhat concentrated, raising concerns about governance capture), and emission sustainability sits at 14/25. The competitive moat dimension scores 18/25.

Scored as: Business
Fee Capture
16/25
Token Distribution
13/25
Emission Sustainability
14/25
Competitive Moat
18/25

Protocol Health: Is Camelot Still Growing?

Camelot's vitality risk score is 7/10 on Hindenrank's rubric (lower is healthier). This raises concerns about protocol vitality — Camelot shows signs of declining activity, stagnant or falling TVL, or reduced developer engagement. Investors should monitor whether this trend reverses before increasing exposure.

GitHub: camelot

Risk-Adjusted View: Is the Upside Worth the Risk?

Risk-Adjusted Position

Blue Chip
High Value
Medium Value
Low Value
High Risk
High Risk Play
Risky
Avoid
Medium Risk
Promising
Neutral
Weak
Low Risk
Camelot
Safe but Stale
Dead Money
See all Blue Chip protocols →

Camelot lands in the Blue Chip quadrant — combining strong value accrual (B-) with low risk (B). This is the most favorable risk-adjusted position, suggesting the protocol delivers real economic value without excessive risk. Protocols in this quadrant are typically suitable as core portfolio holdings.

Risk Context

Camelot carries a risk grade of B (24/100), classified as moderate risk — some novel mechanisms, generally well-understood. While no critical-severity interactions were identified, 2 high-severity interactions warrant attention. The primary risk factor is: No public GitHub codebase and no bug bounty program limit independent security review and vulnerability discovery

Read our full safety analysis →

Should you buy Camelot?

Camelot scores B- on Hindenrank's value accrual framework, placing it among the above-average DEX protocols. Fee capture scores 16/25 — solid, capturing a reasonable share of protocol revenue. Token distribution is somewhat concentrated, raising concerns about governance capture, and emission sustainability sits at 14/25. On the risk side, Camelot carries a B grade (24/100), which is moderate risk — some novel mechanisms, generally well-understood. The combined risk-value position places Camelot in the Blue Chip quadrant.

Camelot investment outlook for 2026

With $20M in total value locked and FDV of $108M, giving a TVL/FDV ratio of 0.19, Camelot's fundamentals support the current valuation from a usage perspective. The competitive moat dimension scores 18/25, suggesting durable structural advantages that are difficult for competitors to replicate.Investors should weigh these fundamentals alongside market conditions and their own risk tolerance.

This analysis is based on cryptoeconomic fundamentals, not price prediction. It is not financial advice. Full methodology

Weekly Commentary

Pro

Week of March 3, 2026

Camelot's B risk grade and Blue Chip quadrant placement make it one of the safer DEX plays in the Arbitrum ecosystem, though the $20M TVL is modest for that classification. The B- value grade suggests fee capture and token economics are decent but not exceptional — you're paying a fair price, not getting a bargain. Solid for conservative DeFi allocators who want DEX exposure without the governance drama of larger venues.

Related DEX Investment Analyses

Related DEX Safety Analyses

Investment analysis uses Hindenrank's value accrual framework across four dimensions: fee capture, token distribution, emission sustainability, and competitive moat. Higher score = better value accrual. Combined with our eight-dimension risk rubric for risk-adjusted positioning. This is not financial advice.